Public opinion about financial incentives for smoking cessation
A partir d'une enquête, menée en 2010 à Philadelphie auprès de 1 010 participants, cette étude évalue l'acceptabilité d'un programme de sevrage tabagique reposant sur l'incitation financière
Objective To assess public support for a smoking cessation policy involving financial incentives. Methods We conducted a randomized controlled trial using an experimental survey design. One of four questionnaire versions was distributed to participants. Each version described a smoking cessation treatment costing $750 per success, including an unspecified treatment, medication, or financial incentive paid to the smoker. Participants indicated whether they would support a $25 increase in their annual health insurance premium to pay for the treatment. Questionnaires were distributed to adults waiting at public transportation depots in Philadelphia between May and August 2010. Results 1,010 individuals completed the question about willingness to support the policy: 53% female, 27% African-American, 18% current smokers, and 46% with a household income below $40,000. Response rate was greater than 50%. Overall support for all smoking cessation treatments was 41.6%. Financial incentive version received the lowest support (39.3%) but that support did not statistically differ from the treatment (45.8%, p = 0.14) or medication (41.7%, p = 0.58) versions. Conclusion Financial incentives were perceived no differently than currently used medications for smoking cessation. Most participants did not support any smoking cessation treatment options.